文献速递慢阻肺呼吸道感染

COVID-19感染对COPD患者长期医疗资源利用的影响

Investigating the Long-Term Effects of COVID-19 Infection on Health Care Utilization in Individuals With COPD.
PubMed 文献 · Chest · 2025-04-02

这项加拿大安大略省的回顾性匹配队列研究纳入31,540对COPD患者,比较COVID-19阳性与阴性者在急性感染期后12周的医疗资源利用(HCU)。阳性者HCU率较阴性者高9%(RR 1.09;95%CI 1.067-1.127),野生型/Alpha/Beta和Omicron变异分别高16%和5%,≥3次疫苗接种者HCU率未显著升高(RR 1.03;95%CI 0.981-1.081)。

要点

  • COPD患者感染COVID-19后长期HCU率显著升高9%。
  • Omicron变异仍与长期HCU率升高5%相关。
  • ≥3次疫苗接种者HCU率与阴性者相似。

核心结论

  • COPD患者COVID-19阳性后长期HCU率显著高于阴性者。
  • Omicron变异仍与长期HCU率显著升高相关。
  • ≥3次疫苗接种者HCU率与阴性者相似,提示疫苗可减少长期HCU。

研究设计与样本

  • 回顾性匹配队列研究,使用加拿大安大略省2020年4月至2022年6月健康行政数据。
  • 纳入医生诊断COPD且接受COVID-19 PCR检测者,阳性与阴性按年龄、性别、疫苗接种状态、PCR日期和倾向评分匹配。
  • 从PCR后12周随访至研究结束,比较每人每年HCU率。
  • 共识别31,540对匹配患者,平均年龄66.4岁,49.9%为男性。

主要发现

  • COVID-19阳性者HCU率较阴性者高9%(RR 1.09;95%CI 1.067-1.127)。
  • 野生型/Alpha/Beta变异HCU率高16%(RR 1.16;95%CI 1.119-1.22)。
  • Omicron变异HCU率高5%(RR 1.051;95%CI 1.01-1.092)。
  • ≥3次疫苗接种者HCU率与阴性者无显著差异(RR 1.03;95%CI 0.981-1.081)。

临床怎么用

  • COPD患者COVID-19感染后需关注长期医疗资源利用增加。
  • Omicron变异感染后仍应警惕长期HCU升高。
  • 建议COPD患者完成≥3次疫苗接种以降低长期HCU。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Individuals with COPD are at elevated risk of severe outcomes following COVID-19 infection. RESEARCH QUESTION: Does COVID-19 have a long-term impact on health care utilization (HCU) for individuals with COPD? STUDY DESIGN AND METHODS: This retrospective matched cohort study was conducted by using health administrative data from Ontario, Canada, between April 2020 and June 2022. Individuals with physician-diagnosed COPD who underwent COVID-19 polymerase chain reaction (PCR) testing were included. Patients positive and negative for COVID-19 were matched on age, sex, vaccination status, PCR test date, and a propensity score. Patients were followed up from the end of the acute infection period (12 weeks after PCR) until the study end date. Per-person per-year HCU rates were captured and compared. Analyses were stratified according to COVID-19 variant eras (wild-type/Alpha/Beta, Delta, and Omicron) and vaccination status (0, 1, 2, and ≥ 3). RESULTS: A total of 31,540 matched pairs were identified. Mean age was 66.4 years, and 49.9% were male. Individuals with positive COVID-19 test results had 9% higher HCU rates than those who tested negative (rate ratio [RR], 1.09; 95% CI, 1.067-1.127). Stratifying according to variant, wild-type/Alpha/Beta and Omicron variants had 16% (RR, 1.16; 95% CI, 1.119-1.22) and 5% (RR, 1.051; 95% CI, 1.01-1.092) higher HCU rates, respectively. Individuals with ≥ 3 vaccinations did not have elevated rates of HCU (RR, 1.03; 95% CI, 0.981-1.081) compared with those who tested negative. INTERPRETATION: In this study, patients with COPD who were positive for COVID-19 had significantly greater long-term HCU usage. Although Omicron has been considered milder than previous variants, it was still associated with significantly elevated long-term HCU. Individuals with ≥ 3 vaccinations who tested positive for COVID-19 had HCU rates similar to those who tested negative, suggesting that vaccinations can reduce long-term HCU.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Munn JS, Austin PC, Atzema CL, et al. Investigating the Long-Term Effects of COVID-19 Infection on Health Care Utilization in Individuals With COPD. Chest. 2025. PMID: 40185364. doi:10.1016/j.chest.2025.02.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。